Computational-Based Mechanistic Study and Engineering of Cytochrome P450 MycG for Selective Oxidation of 16-Membered Macrolide Antibiotics

MycG is a cytochrome P450 that performs two sequential oxidation reactions on the 16-membered ring macrolide M‑IV. The enzyme evolved to oxidize M‑IV preferentially over M‑III and M‑VI, which differ only by the presence of methoxy vs free hydroxyl groups on one of the macrolide sugar moieties. We ut...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American Chemical Society 2020-10, Vol.142 (42), p.17981-17988
Hauptverfasser: Yang, Song, Grandner, Jessica M, Olson, Noelle M, Anzai, Yojiro, Sherman, David H, Houk, K. N
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:MycG is a cytochrome P450 that performs two sequential oxidation reactions on the 16-membered ring macrolide M‑IV. The enzyme evolved to oxidize M‑IV preferentially over M‑III and M‑VI, which differ only by the presence of methoxy vs free hydroxyl groups on one of the macrolide sugar moieties. We utilized a two-pronged computational approach to study both the chemoselective reactivity and substrate specificity of MycG. Density functional theory computations determined that epoxidation of the substrate hampers its ability to undergo C–H abstraction, primarily due to a loss of hyperconjugation in the transition state. Metadynamics and molecular dynamics simulations revealed a hydrophobic sugar-binding pocket that is responsible for substrate recognition/specificity and was not apparent in crystal structures of the enzyme/substrate complex. Computational results also led to the identification of other interactions between the enzyme and its substrates that had not previously been observed in the cocrystal structures. Site-directed mutagenesis was then employed to test the effects of mutations hypothesized to broaden the substrate scope and alter the product profile of MycG. The results of these experiments validated this complementary effort to engineer MycG variants with improved catalytic activity toward earlier stage mycinamicin substrates.
ISSN:0002-7863
1520-5126
DOI:10.1021/jacs.0c04388